Caplyta

Intra-Cellular reports positive Phase III trial of Caplyta in MDD and bipolar depression
Clinical Trials Arena
Wed, 03/29/23 - 09:40 am
Intra-Cellular Therapies
clinical trials
Caplyta
major depressive disorder
bipolar disorder
Vaccine Stocks Are Rising, but This Biotech Is Monday's Big Nasdaq Winner
Motley Fool
Mon, 12/20/21 - 10:57 am
biotech stocks
NASDAQ
vaccines
Novavax
Moderna Therapeutics
Ocugen
Intra-Cellular Therapies
Caplyta
Important catalysts approach for smaller biotechs
EP Vantage
Wed, 06/24/20 - 10:35 am
BeiGene
Turning Point Therapeutics
Intra-Cellular Therapies
Immunovant
Caplyta
Brukinsa
repotrectinib
IMVT-1401
clinical trials
Intra-Cellular approval keeps focus on FDA's neuroscience review process
BioPharma Dive
Thu, 12/26/19 - 01:05 pm
FDA
Intra-Cellular Therapies
lumateperone
schizophrenia
Caplyta